<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686201</url>
  </required_header>
  <id_info>
    <org_study_id>Diabetes Apps</org_study_id>
    <nct_id>NCT04686201</nct_id>
  </id_info>
  <brief_title>Development of Diabetes Mobile Application</brief_title>
  <official_title>Development of Diabetes Mobile Application &quot;MyD App&quot; To Improve Patient's Knowledge, Compliance and Control: An Interventional Study Among Uncontrolled Type 2 Diabetes Mellitus Patients in Kedah, Malaysia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University of Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University of Malaysia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this study is to measure the effectiveness of a diabetes mobile application for improving&#xD;
      patient's knowledge, compliance and diabetes control among uncontrolled Type 2 Diabetes&#xD;
      Mellitus mellitus patients in Kedah&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Objective&#xD;
&#xD;
        1. To develop and validate a diabetes mobile-app (MyD-App) for patients with uncontrolled&#xD;
           Type 2 Diabetes Mellitus.&#xD;
&#xD;
        2. To measure the effectiveness of a diabetes mobile application for improving knowledge,&#xD;
           compliance and control using the newly developed and validated MyD-App among patients&#xD;
           with uncontrolled Type 2 Diabetes Mellitus.&#xD;
&#xD;
      Hypothesis&#xD;
&#xD;
        1. There is an increased in patient's knowledge on diabetes after MyD-App usage.&#xD;
&#xD;
        2. There is an increased in patient's compliance on medication and treatment after MyD-App&#xD;
           usage.&#xD;
&#xD;
        3. There is a diabetes control improvement (HbA1C &lt; 6.5% or HbA1C reduction â‰¥ 1%) among&#xD;
           Type 2 Diabetes Mellitus patients in Kedah after MyD-App usage.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of uncontrolled Diabetes Mellitus patients who have good knowledge after using Diabetes Mobile Application</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of uncontrolled Diabetes Mellitus patients who have good knowledge after using Diabetes Mobile Application (assessment using Michigan Diabetes Knowledge Test Questionnaire)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of uncontrolled Diabetes Mellitus patients who have good compliance after using Diabetes Mobile Application</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of uncontrolled Diabetes Mellitus patients who have good compliance after using Diabetes Mobile Application (assessment using Malaysia Medication Adherence Assessment Tool (MyMAAT) for diabetic patients)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of uncontrolled Diabetes Mellitus patients who have good control diabetes after using Diabetes Mobile Application</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of uncontrolled Diabetes Mellitus patients who have good control diabetes (HbA1C 7% or more than 1% reduction of HbA1C) after using Diabetes Mobile Application</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diabetes Mobile Application</intervention_name>
    <description>incorporating mobile application usage in managing diabetes mellitus patient in health clinics</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-80 years old&#xD;
&#xD;
          -  Diagnosed with type 2 diabetes mellitus by a registered medical doctor.&#xD;
&#xD;
          -  Registered and actively follow up in the health clinics at selected districts.&#xD;
             (actively follow up: follow up at the clinic for at least once in a year).&#xD;
&#xD;
          -  Own a smartphone with the Android platform.&#xD;
&#xD;
          -  HbA1C &gt;7%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  GDM&#xD;
&#xD;
          -  Illiterate&#xD;
&#xD;
          -  Anemia / Thalassemia&#xD;
&#xD;
          -  Not agree to be the sample for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MOHD ROHAIZAT HASSAN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MOHD ROHAIZAT HASSAN, PhD</last_name>
    <phone>+60126343303</phone>
    <email>rohaizat@ppukm.ukm.edu.my</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MOHD NAZRIN JAMHARI, MPH</last_name>
    <phone>+60173287707</phone>
    <email>drmohdnazrin@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jabatan Kesihatan Negeri Kedah</name>
      <address>
        <city>Alor Setar</city>
        <state>Kedah</state>
        <zip>05400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MOHD NAZRIN JAMHARI, MPH</last_name>
      <phone>0173287707</phone>
      <email>drmohdnazrin@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 20, 2020</study_first_submitted>
  <study_first_submitted_qc>December 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 24, 2020</last_update_submitted>
  <last_update_submitted_qc>December 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

